|
Match
|
Document |
Document Title |
|
|
5366965 |
Regimen for treatment or prophylaxis of osteoporosis
Methods for treating or preventing osteoporosis, including regimens for intermittent dosing of bone resorption inhibiting polyphosphonate compound or a pharmaceutically acceptable salt or ester of...
|
|
|
5356887 |
Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids
Crystalline and amorphous insoluble calcium salts of bisphosphonic acids may be formulated to provide compositions suitable for I.M. (intramuscular) and S.C. (subcutaneous) administration. As...
|
|
|
5344825 |
Methanediphosphonic acid formulations with ion exchangers
The invention relates to a novel advantageous oral dosage form for methanediphosphonates, especially the active ingredient disodium pamidronate. A preferred dosage form comprises: a)...
|
|
|
5338731 |
Bisphosphonates, processes for preparation and pharmaceutical compositions containing the same
Bisphosphonate compounds are of the Formula (I): ##STR1## wherein Y is O or N--OH and n is from 3 to 24, and further wherein when Y is O, (i) R 1 is hydrogen and R 2 is sodium, or (ii) R...
|
|
|
H001345 |
Method for preventing or treating hepatitis D
A method is provided for blocking or preventing the prenylation of CXXX box containing proteins thereby preventing and/or treating hepatitis D which includes the step of administering a...
|
|
|
5332728 |
Method for treating a fungal infection
A method is provided for treating a fungal infection which includes the step of administering a therapeutically effective amount of a phosphorus-containing squalene synthetase inhibitor.
|
|
|
5296475 |
Pharmaceutical compositions comprising methanediphosphonic acid derivatives and macrocyclic polyethers
The invention relates to pharmaceutical compositions for peroral administration comprising (a) pharmaceutically useful methanediphosphonic acid derivatives, e.g. those of formula I ##STR1## wherein...
|
|
|
5294608 |
Guanidinoalkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use
The invention describes tautomeric compounds of the formula Ia, Ib or Ic ##STR1## and/or their physiologically tolerable salts, in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are a hydrogen...
|
|
|
5273969 |
Phosphorus-containing squalene synthetase inhibitors and method
Compounds which are inhibitors of cholesterol biosynthesis (by inhibiting de novo squalene biosynthesis), and thus are useful as hypocholesterolemic agents and antiatherosclerotic agents are...
|
|
|
5270365 |
Prevention and treatment of periodontal disease with alendronate
This invention claims a method for treating periodontal disease in mammals, including humans, by administering an effective amount of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or a...
|
|
|
5260287 |
Polyphosphorylated organic compounds: compositions useful in protecting biological tissues
Compositions and methods for protecting the luminal lining against gastric acid challenge are disclosed. The compositions provide effective anti-ulcer preparations which include phosphorylated...
|
|
|
5254544 |
Hydroxyphosphinyl phosphonate squalene synthetase inhibitors and method
Hydroxyphosphinyl phosphonate compounds are provided which inhibit the enzyme squalene synthetase and thereby inhibit cholesterol biosynthesis. These compounds have the formula ##STR1## wherein R 2...
|
|
|
5227506 |
Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
The invention relates to acyloxymethyl esters of bisphosphonic acids, halo-bisphosphonic acids and hydroxy-bisphosphonic acids which exhibit oral bioavailability and are useful in the treatment of...
|
|
|
5212164 |
Phosphorus-containing squalene synthetase inhibitors
Compounds which are inhibitors of cholesterol biosynthesis (by inhibiting de novo squalene biosynthesis), and thus are useful as hypocholesterolemic agents and antiatherosclerotic agents are...
|
|
|
5196409 |
Bisphosphonates, pharmaceutical compositions, and process for the treatment of irregularities in calcium metabolism
Novel bisphosphonates comprise compounds of the formula (I) ##STR1## wherein m and l are independently 1 or 2; R 1 represents hydrogen, a lower alkyl group, or an alkali metal cation; R 2 ...
|
|
|
5157027 |
Bisphosphonate squalene synthetase inhibitors and method
Compounds which are inhibitors of cholesterol biosynthesis (by inhibiting de novo squalene biosynthesis), and thus are useful as hypocholesterolemic agents and antiatherosclerotic agents are...
|
|
|
5120721 |
Acaricidal composition
An acaricidal composition comprising as active ingredients (A) either α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate or α-cyano-3-phenoxybenzyl...
|
|
|
5096717 |
Double-coated granules of disodium pamidronate
The invention relates to an advantageous oral administration from the disodium pamidronate in capsules. These capsules are filled with double-coated granules. The inner coating is hydrophilic and...
|
|
|
5037812 |
Tumor cell growth-inhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes
Pharmaceutical compositions and a method for inhibiting the growth of tumor cells by administering a tumor cell growth-inhibiting amount of a bis[bis (diphenylphosphino)hydrocarbon]-,...
|
|
|
5002937 |
Diphosphonic acid compounds and use for calcium metabolism disorders
The present invention provides compounds of the formula: ##STR1## The present invention also provides processes for the preparation of these compounds and pharmaceutical compositions containing...
|
|
|
4975423 |
Inhibition of tumor development
Non-toxic water-soluble pharmaceutically acceptable compound derivative of peroxydiphosphoric acid when administered orally or systemically supplements inhibition of malignant myeloma carcinoma...
|
|
|
4957939 |
Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
Pharmaceutical compositions comprising gadolinium chelates are useful for enhancing NMR images.
|
|
|
4942157 |
1-hydroxy-3-(N-methyl-N-propylamino)propane-1,1-diphosphonic acid, pharmaceutical compositions and methods of use
The present invention provides 1-Hydroxy-3-(N-methyl-N-propylamino)propane-1,1-diphosphonic
acid of formula ##STR1## wherein R is hydrogen or C 1 -C 4 alkyl and the pharmacologically acceptable...
|
|
|
4927814 |
Diphosphonate derivatives, pharmaceutical compositions and methods of use
The present invention provides disphosphonates of the general formula: ##STR1## wherein R 1 is a straight-chain or branched, saturated or unsaturated aliphatic hydrocarbon radical of 1-9 carbon...
|
|
|
4892679 |
Oxa-alkane polyphosphonic acids, their use as thresholders, and complexing compositions containing these compounds
Oxa-alkane polyphosphonic acids corresponding to general formula (I) ##STR1## in which R 1 is a C 1 -C 10 alkyl group, an optionally substituted C 6 -C 10 aryl group, a phenyl- or...
|
|
|
4876248 |
Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation
The present invention relates to products of the formula ##STR1## where R 1 is H or alkyl, n is an integer from 0 to 10, and R 2 is chosen from amongst H, unsubstituted or substituted alkyl...
|
|
|
4857513 |
Diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
A compound of the formula: ##STR1## wherein R 1 --A-- is a group of the formula: ##STR2## in which R 1 is aryl or a heterocyclic group, each of which may be substituted with substituent(s)...
|
|
|
4851217 |
All aqueous formulations of organo-phosphorous pesticides
A composition of matter and method of making the composition which relates to an all aqueous, phase stable emulsion of organophosphorous pesticides which is free of organic solvents. The...
|
|
|
4820698 |
Antimicrobial agents and process for their manufacture
Disclosed are tetraalkyl enthenylidenebisphosphonates and a method for their manufacture. These compounds are suitable for use as antimicrobial agents in combating a number of pathogenic...
|
|
|
4814326 |
Pharmaceutical compositions based on diphosphonates for the treatment of arthrosis and osteoarthritis
This invention relates to pharmaceutical compositions for the treatment of arthrosis by intraarticular administration of the compositions diluted in a suitable aqueous or lyophilized carrier,...
|
|
|
4719050 |
Diphosponylated oxonitriles, processes and uses therefor, and compositions containing them
3-Alkyl-3-oxo-1-aminopropane-1,1-diphosphonic acids and water-soluble salts thereof corresponding to the formula ##STR1## in which R 1 represents an unbranched or branched C 1 -C 8 alkyl group,...
|
|
|
4719203 |
Diphosphonic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
Diphosphonate compounds, processes for their preparation and pharmaceutical compositions containing them and being useful for treating calcium metabolism disorders. The diphosphonates are of the...
|
|
|
4666895 |
Diphosphonic acid derivatives
The present invention provides diphosphonic acid derivatives of the general formula: ##STR1## wherein R 1 , R 2 , R 3 , R 4 and R 5 , independently of one another or also together, signify...
|
|
|
4645762 |
Diphosphonic acid derivatives and pharmaceutical preparations containing same
Diphosphonic acid derivatives of the formula ##STR1## wherein X is cyano, 2-cyanoethyl, or 3- aminopropyl and Y is H, or X and Y together represent dimethylaminomethylene ((CH 3 ) 2 NCH), and ...
|
|
|
4634691 |
Method for inhibiting tumor metastasis
A method for inhibiting the formation of tumor cell metastases without treating the underlying cancer itself in humans and animals having metastatic cancer involving the skeleton is disclosed. In...
|
|
|
4624695 |
O-diaminophosphinyl derivatives of oximes as urease inhibitors
The invention relates to novel urease inhibited fertilizer compositions containing urea and a urease inhibiting amount of one or more o-diaminophosphinyl derivatives of oximes, and methods and...
|
|
|
4624947 |
4-dimethylamino-1-hydroxybutane-1,1-diphosphonic acid, salts thereof, and processes therefor
4-Dimethylamino-1-hydroxybutane-1,1-diphosphonic acid and water-soluble salts thereof, methods for their preparation, and uses thereof as complexing agents.
|
|
|
4621077 |
Pharmacologically active biphosphonates, process for the preparation thereof and pharmaceutical compositions therefrom
Biphosphonic acids of general formula I: ##STR1## in which R is a fluorine atom of a linear or branched alkyl radical containing between 1 and 5 carbon atoms, which may also be substituted by one...
|
|
|
4578376 |
Pharmaceutical compositions for the treatment of osteopathias
A pharmaceutical composition for the treatment of osteopathias is described which contains an effective amount of the active ingredient 6-amino-1-hydroxyhexane-1,1-diphosphonic acid or a...
|
|
|
4446052 |
Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
Calcium 1-hydroxy-3-aminopropane-1,1-diphosphonate forms a gel when mixed with water. As compared to soluble salts of APD, the gel provides slow systemic release and reduced tissue damage when used...
|
|
|
4357329 |
Combating pests with N-phosphonylcarbonyl-carbamates
N-Phosphonylcarbonyl-N-methylcarbamic acid esters of the formula ##STR1## in which R 1 and R 2 can be identical or different and each represents alkyl, alkenyl or alkynyl, it being possible for...
|
|
|
4330530 |
Anti-arthritic compositions and method using gold salts and organophosphonates
Compositions comprising pharmaceutically-acceptable gold salts and organophosphonates, especially the geminal diphosphonates, useful in the treatment of arthritic conditions, are disclosed. The...
|
|
|
4330537 |
Compositions for inhibiting mobilization of calcium phosphate in animal tissue
Compositions for inhibiting the anomalous mobilization of calcium phosphates in animal tissue comprising an effective amount of certain phosphonate compounds as herein defined in combination with...
|
|
|
4282214 |
Phenylacetate anti-inflammatory composition
The anti-inflammatory activity of fenoprofen, ketoprofen, MK-830 and other phenylacetic acid-based anti-inflammatory drugs is enhanced by administration thereof in conjunction with a phosphonate...
|
|
|
4275059 |
Salicylate anti-inflammatory composition
The anti-inflammatory activity of aspirin and other salicylate-based, anti-inflammatory drugs is enhanced by administration thereof in conjunction with a phosphonate compound such as EHDP or Cl 2 ...
|
|
|
4269828 |
Indole anti-inflammatory composition
The anti-inflammatory activity of indomethacin, indoxole, and other indole-based drugs is enhanced by administration thereof in conjunction with a phosphonate compound such as EHDP or Cl 2 MDP.
|
|
|
4264582 |
Isobutylphenylacetate anti-inflammatory composition
The anti-inflammatory activity of ibuprofen, ibufenac and other p-(isobutylphenyl)acetic acid-based anti-inflammatory drugs is enhanced by adminstration thereof in conjuction with a phosphonate...
|
|
|
4254114 |
Control of pyrophosphate microorganisms with organophosphonates
A method of selectively controlling pyrophosphate-utilizing microorganisms comprises contacting said microorganisms with an organism controlling amount of certain organophosphonate compounds....
|
|
|
4234645 |
Pharmaceutical composition
Dichloromethane diphosphonates affect the biosynthesis of collagen.
|
|
|
4230700 |
Methods for inhibiting mobilization of calcium phosphate in animal tissue
Compositions for inhibiting the anomalous mobilization of calcium phosphates in animal tissue comprising an effective amount of certain phosphonate compounds as herein defined in combination with...
|